Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Bone ; 187: 117192, 2024 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-38969279

RESUMO

Osteogenesis imperfecta (OI)is a rare genetically heterogeneous disorder caused by changes in the expression or processing of type I collagen. Clinical manifestations include bone fragility, decreased linear growth, and skeletal deformities that vary in severity. In typically growing children, skeletal maturation proceeds in a predictable pattern of changes in the size, shape, and mineralization on the hand and wrist bones that can be followed radiographically known at the bone age. Assessment of bone age can be clinically used to assess time remaining for linear growth, and the onset and duration of puberty, both of which can be useful in determining the timing of some surgeries or the interpretation of other imaging modalities such as bone densitometry. Additionally, deviations in the expected maturation process of the bone age may prompt or assist in the work up of a significant delay or advancement in a child's growth pattern. The primary aim of our study was to determine whether the bone age in children with a skeletal disorder such as OI follow the same pattern and rate of bone maturation compared to a control population. Using participants from the Natural History Study of the Brittle Bone Disorders Consortium, we analyzed 159 left hand and wrist radiographs (bone age) for a cross-sectional analysis and 55 bone ages repeated at approximately 24 months for a longitudinal analysis of skeletal maturation. Bone ages were read by a pediatric endocrinologist and by an automated analysis using a program called BoneXpert. Our results demonstrated that in children with mild-to-moderate OI (types I and IV), the skeletal maturation is comparable to chronological age-mated controls. For those with more severe forms of OI (type III), there is a delayed pattern of skeletal maturation of less than a year (10.5 months CI 5.1-16) P = 0.0012) at baseline and a delayed rate of maturation over the two-year follow up compared to type I (P = 0.06) and type III (P = 0.02). However, despite these parameters being statistically different, they may not be clinically significant. We conclude the bone age, with careful interpretation, can be used in the OI population in a way that is similar to the general pediatric population.


Assuntos
Desenvolvimento Ósseo , Osteogênese Imperfeita , Puberdade , Humanos , Osteogênese Imperfeita/diagnóstico por imagem , Criança , Masculino , Feminino , Estudos Transversais , Estudos Longitudinais , Adolescente , Puberdade/fisiologia , Determinação da Idade pelo Esqueleto , Pré-Escolar
2.
Rev. Inst. Med. Trop. Säo Paulo ; 30(3): 208-10, maio-jun. 1988. tab
Artigo em Português | LILACS | ID: lil-53312

RESUMO

Em inquérito realizado na zona urbana de Cáceres (Mato Grosso, Brasil) foram estudados 485 homens e 766 mulheres maiores de 10 anos de idade. Neles a prevalência de Hipertensäo arterial foi de 12,2%. Os critérios utilizados foram os propostos pela OMS. As mulheres apresentaram prevalência maior que a dos homens, e em ambos os sexos a prevalência aumenta com a idade. Dentre os hipertensos poucos titinham consciência de seu estado e raros estavam em tratamento


Assuntos
Criança , Adolescente , Adulto , Pessoa de Meia-Idade , Masculino , Feminino , Hipertensão/epidemiologia , Pressão Arterial , Brasil
3.
New Delhi; World Health Organization. Regional Office for South-East Asia; 2018. , 8, 1
em Inglês | WHOLIS | ID: who-259941

RESUMO

The Asia Pacific Observatory on Health Systems and Policies (the APO) is a collaborative partnership of interested governments, international agencies, foundations, and researchers that promotes evidence-informed health systems policy regionally and in all countries in the Asia Pacific region. The APO collaboratively identifies priority health system issues across the Asia Pacific region; develops and synthesizes relevant research to support and inform countries' evidence-based policy development; and builds country and regional health systems research and evidence-informed policy capacity.


Assuntos
Japão , Planos de Sistemas de Saúde , Organização do Financiamento , Atenção à Saúde
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa